0001714218-17-000001.txt : 20170816 0001714218-17-000001.hdr.sgml : 20170816 20170816101622 ACCESSION NUMBER: 0001714218-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170816 DATE AS OF CHANGE: 20170816 EFFECTIVENESS DATE: 20170816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Go Therapeutics, Inc. CENTRAL INDEX KEY: 0001714218 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-292903 FILM NUMBER: 171035537 BUSINESS ADDRESS: STREET 1: ONE BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-816-4637 MAIL ADDRESS: STREET 1: ONE BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001714218 Go Therapeutics, Inc. ONE BROADWAY CAMBRIDGE MA MASSACHUSETTS 02142 617-816-4637 DELAWARE GlycoZym USA, Inc. None Corporation true Constantine Theodoropulos c/o Go Therapeutics, Inc. One Broadway Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Gregory L. Chase c/o Go Therapeutics, Inc. One Broadway Cambridge MA MASSACHUSETTS 02142 Director Thayer White c/o Go Therapeutics, Inc. One Broadway Cambridge MA MASSACHUSETTS 02142 Director Pharmaceuticals Decline to Disclose 06b false 2017-08-02 false true false 0 4999999 4999999 0 false 1 0 0 0 false Go Therapeutics, Inc. /s/ Constantine Theodoropulos Constantine Theodoropulos Chief Executive Officer 2017-08-08